More so than almost all other scientific fields, our knowledge, understanding and expertise in biology has increased at a phenomenal pace over the past few decades. Since the high throughput sequencing power used in the human genome project was unleashed at the beginning of the 21st century, multiple '-omics' disciplines now characterise a diverse field that offers such enormous potential for medicine, food production, wellbeing and human expression.
As we now understand much more about the most complex of biological systems, inventors and innovators are able to address the most pressing and impactful needs we face today.
Thank you
The most cutting-edge life sciences businesses have become adept at marrying advances in computer technology with the power of automation to make rapid improvements and enhancements to our ability to understand and address complex challenges. These technology-led developments have become almost as important to their operations as knowledge of the underlying biological factors involved. These businesses are at the forefront of research and development, and we are delighted to play our part in helping them to thrive for the wider benefit of society.
Our team of attorneys have PhDs and real world research and development experience from the most prestigious institutions in Europe and the UK. We are highly experienced in multiple disciplines from biologics and therapeutics to diagnostics and modelling, from regenerative medicine to synthetic biology and bioinformatics.
Our attorneys combine technical excellence with business insight to act for a wide range of clients from those at the earliest stage of their commercial journey where we can guide the development and implementation of an intellectual property portfolio through to multinational corporations, acting as an extension of their teams.
Keltie’s work in the life sciences sector includes:
The life science team at Keltie is resolutely commercial in our approach to intellectual property protection. The underlying business case is as important for framing our advice as the nature of the technology itself. Our team of attorneys in both the patents and trade marks handle matters of global importance. As a result we are adept at advising on issues that cover multiple markets from Europe to North America, Asia and beyond.
Our approach focuses on putting together the best team of attorneys for your business’ needs from our diverse talent pool to ensure your intellectual property portfolio is planned, executed and maintained to the highest standards to safeguard your rights.
Sectors you may be interested in
People who work in this area
Sectors we work in
12.08.2025
Edwards vs Meril case at the Unified Patent CourtIn this article, Molly Yau looks at the Edwards vs Meril case at the Unified Patent Court (UPC), and explores its procedural implications. Molly draws on her academic background and long-standing interest in cardiovascular devices to introduce key technical details of the case - which relates to implantable prosthetic heart valves and delivery systems - and highlights the decision’s significance for UPC practice.
29.04.2025
Case Law Review: Board of Appeal Decision T 1741/22Patent applications related to data processing often fall foul of the EPO’s exclusions on “mathematical methods”. Applicants in the MedTech space in particular may find it far easier to protect the hardware in their wearable devices and tools than to protect the software that processes and analyses that data. A recent board of appeal decision T 1741/22 seems to contradict the Guidelines for Examination and previous Board of Appeal decisions. This decision may shed some light on how the EPO may approach these data processing applications in future.
09.12.2025 - 10.12.2025
SynbiTECH 2025Keltie is proud to be sponsoring and exhibiting at SynbiTECH 2025. Laura Kehoe, Asawari Churi, and Devanand Crease will be attending, with Devanand speaking on the second day.
Thank you
